Urolithin A supplements have moved from niche research curiosity to mainstream health store shelf in a few short years. As the market grows, so does the variation in label language, dosing claims, and ingredient sourcing. Knowing how to parse a supplement label can help you compare products more honestly and set realistic expectations before you spend money.
This guide walks through each part of a urolithin A label, from the active ingredient declaration to the fine print, and explains what the terminology means, what evidence supports specific claims, and where the science still has gaps. Nothing here constitutes medical advice, and a doctor or registered dietitian is the right person to consult before starting any supplement.
Key Takeaways
- Check whether the label declares urolithin A (the finished molecule) or a precursor such as ellagic acid or pomegranate extract: these are not the same thing, and conversion from precursor to UA still depends on your gut microbiome.
- Read the serving size line carefully: per-capsule dose and per-serving dose can differ significantly, and the total number of doses in a container depends on both.
- In a study of standardized black raspberry foods, urinary ellagitannin metabolites rose with dietary intake, which does not show that supplement label doses track blood levels [8][9][1], but label dose is not the same as systemic exposure: individual absorption varies.
- Third-party certificates of analysis and recognized quality seals (NSF, USP, Informed Sport) are among the few independent checks on whether a product contains what it claims at the stated potency.
- Avoid products that make disease treatment claims, hide urolithin A inside an undisclosed proprietary blend, or cannot provide a recent CoA on request: these are markers of low transparency, not high quality.
What Urolithin A Is and Why It Appears on Labels
Urolithin A (UA) is a small molecule produced when gut bacteria metabolize ellagitannins: polyphenols found in pomegranate, walnuts, and some berries. The conversion happens in the colon; the compound is then absorbed into circulation. Early research has investigated its potential to stimulate mitophagy, the selective removal and recycling of damaged mitochondria, which is one reason it attracts interest in the context of healthy aging and exercise recovery.
When you see ‘urolithin A’ on a supplement label, the manufacturer is declaring that the capsule or powder contains the finished molecule itself, not the polyphenol precursors you would need to consume and then convert through your own gut bacteria. This distinction matters because individual gut microbiome composition affects how efficiently a person converts dietary ellagitannins into urolithin A, making direct supplementation with the finished molecule a way to sidestep that variability entirely.
Active Ingredient: What Form Is Actually Listed?
The most important line on any urolithin A label is the active ingredient declaration. Products fall into two broad categories: those containing synthesized or fermentation-derived urolithin A and those containing pomegranate-derived extracts enriched in urolithin A precursors. Researchers have developed and validated preparative methods to isolate and purify urolithins from natural sources [2], and reputable manufacturers draw on similar analytical techniques to verify identity and concentration in finished products.
Research note: After 4 months of daily dosing, plasma parent urolithin A was 1038 pg/mL while its glucuronide conjugate was 1014 ng/mL, so most circulating urolithin A is in the conjugated form [13].
A label that says ‘urolithin A (synthetic)’ or ‘urolithin A (fermentation-derived)’ names the finished molecule. A label that says ‘pomegranate extract standardized to X% ellagic acid’ names a precursor-rich ingredient, not urolithin A itself. Ellagic acid is a breakdown product of ellagitannins and a metabolic stepping stone toward urolithin A, but additional gut conversion is still required after ingestion. Neither form is inherently superior for all consumers, but knowing the difference lets you compare products accurately.
Synthesis routes and chemical characterization of urolithin A have been documented in peer-reviewed research, including work on novel urolithin A conjugates [3]. When a brand claims a proprietary synthesis pathway or a patented form, look for independent analytical data to support that claim rather than accepting the marketing language at face value.
Dose and Serving Size: Reading the Numbers Carefully
Dose declarations on urolithin A labels typically range from 250 mg to 1,000 mg per serving. A dose-response relationship between polyphenol intake and measurable ellagitannin metabolite levels in urine has been demonstrated in controlled human research [1], but that was dietary ellagitannin intake, not supplement doses. People also differ widely in how much urolithin A they make from the same food, so a higher label dose is not a guarantee of higher exposure [8][9].
However, the serving size line requires careful reading. Some products list the dose per single capsule; others list a two- or three-capsule serving. A product advertising ‘1,000 mg urolithin A’ may require four capsules to reach that number. Check the ‘serving size’ box at the top of the Supplement Facts panel, confirm how many units constitute one serving, and calculate how many doses the container actually contains. A 60-capsule bottle with a two-capsule serving contains 30 doses, not 60.
Bioavailability: What Labels Cannot Capture
A label can tell you how much urolithin A is in a capsule, but it cannot tell you how much reaches your bloodstream. Researchers studying pomegranate-derived polyphenol pharmacokinetics in humans have found that absorption curves, peak plasma concentrations, and elimination profiles vary between individuals and between food matrix contexts [4]. Validated mass spectrometry methods now allow precise measurement of urolithin A levels in human plasma [5], but these techniques are used in clinical trials, not by consumers at home.
Animal studies confirm that urolithin A is absorbed after oral ingestion [6], but translating rodent pharmacokinetic data to human predictions carries well-known limitations. A label showing 500 mg does not guarantee 500 mg of systemic exposure. Factors including gut transit time, concurrent food intake, and individual microbiome composition all modulate what ends up in circulation. Treat the stated dose as a reference point, not a precise pharmacological promise.
Third-Party Testing and Quality Seals
Because dietary supplements are not approved by regulatory agencies before sale in most markets, third-party testing is one of the few independent checks on label accuracy. Look for certificates of analysis (CoA) from independent laboratories and recognizable quality seals such as NSF International, USP, or Informed Sport. These programs test for identity (is the ingredient what the label says?), potency (does the dose match the label?), and in some programs, the absence of contaminants or banned substances.
A CoA should specify the analytical method used for urolithin A quantification. High-performance liquid chromatography coupled to mass spectrometry is the established technique for polyphenol identification and concentration verification in finished products [5]. If a brand cannot or will not share a recent CoA on request, that is a meaningful transparency gap. Price is not a reliable proxy for quality: some expensive products lack rigorous testing, and some mid-range products maintain strong programs.
Other Ingredients and Red Flags in the Fine Print
Below the Supplement Facts panel you will find the ‘Other Ingredients’ list: fillers, flow agents, capsule materials, and excipients. Common entries include microcrystalline cellulose, silicon dioxide, magnesium stearate, and gelatin or vegetable cellulose for the capsule shell. Consumers with specific dietary requirements should check capsule materials for vegan, kosher, or halal compliance, and those with known sensitivities should scan the list for potential allergens.
Some products add complementary ingredients alongside urolithin A. Pomegranate extract appears as a co-ingredient in several formulations; diets rich in polyphenol-containing foods including pomegranate have been associated with lower cardiovascular disease risk markers in large epidemiological research [7], though a supplement is not equivalent to a dietary pattern. Watch for ‘proprietary blend’ language that groups urolithin A and other ingredients under a single combined weight: this structure prevents you from knowing the actual dose of each individual component.
Legitimate labels make structure-function claims, not disease claims. Language such as ‘supports mitochondrial health’ is permitted; language claiming to treat or reverse a specific disease is a regulatory violation and a quality warning sign. Claims of ‘clinically proven dose’ without naming a specific study or dose range are similarly unfalsifiable marketing, and should prompt skepticism rather than confidence.
The same caution applies to labels or product pages that say a urolithin A is “FDA reviewed” or “GRAS”. FDA’s response to GRAS notice 791 says it has no questions about the notifier’s conclusion for food uses such as protein shakes, bars and yogurts, states that the letter is not an affirmation of GRAS status, and says FDA did not evaluate labeling claims [12].
đź›’ Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The research on urolithin A in humans is still maturing, with most clinical trials being short-term and involving small sample sizes; long-term effects and optimal dosing across diverse populations have not been established. Individuals who are pregnant, breastfeeding, taking prescription medications, or managing a chronic health condition should consult a qualified healthcare provider before adding any urolithin A supplement to their routine.
Frequently Asked Questions
What is the difference between urolithin A and ellagic acid on a label?
Ellagic acid is a polyphenol released from ellagitannins during digestion and a metabolic precursor, not urolithin A itself. Your gut bacteria must convert it further before urolithin A is produced. Researchers studying pomegranate polyphenol pharmacokinetics in humans have tracked this multi-step conversion process [4], and the efficiency of that conversion varies substantially between individuals. A label declaring urolithin A names the finished compound; a label declaring ellagic acid names an upstream intermediate.
Is there an established standard dose for urolithin A?
No single universally agreed dose currently exists. Human research has used a range of amounts, and controlled studies have found that measurable ellagitannin metabolite levels in urine scale with the quantity consumed [1]. Most commercial products fall in the 250 to 1,000 mg per serving range. The appropriate dose for a given individual is best discussed with a healthcare provider familiar with the relevant clinical research.
How can I verify that a urolithin A product has been independently tested?
Look for a certificate of analysis from a third-party laboratory on the brand’s website, or check for quality program seals from bodies such as NSF International or USP. Mass spectrometry-based methods are the standard analytical approach for confirming urolithin A identity and concentration in a finished supplement [5]. If no CoA is publicly posted, contact the manufacturer directly and ask for one dated within the past 12 months.
Are the ellagitannin precursors in pomegranate supplements safe at high doses?
Animal safety studies have examined repeated high doses of punicalagin: a major ellagitannin in pomegranate , and found no toxicity in rats over 37 days at substantial dose levels . However, the authors of that rat study called for human safety evaluation, animal safety data do not automatically translate to human equivalents, a review of published data argued that urolithins should be further evaluated for high-dose toxicity, and extensive long-term human safety data for high-dose urolithin A supplementation remain limited [10][11]. Standard supplemental doses appear well tolerated based on available evidence, but high-dose protocols have not been studied extensively in humans.
Can a diet rich in pomegranate and berries replace a urolithin A supplement?
Dietary polyphenols from foods such as pomegranate, walnuts, and berries provide the ellagitannin precursors gut bacteria need to produce urolithin A. Diets high in such polyphenols, including the Mediterranean pattern, have been associated with lower cardiovascular disease risk markers in large epidemiological research [7]. However, gut conversion efficiency varies widely: some individuals produce meaningful amounts of urolithin A from food, while others produce very little regardless of intake. A supplement delivering the finished molecule bypasses this variability.
What does 'standardized extract' mean when it appears on a urolithin A label?
Standardization means the manufacturer has tested the raw ingredient and adjusted the formulation so that each production batch consistently delivers a declared percentage of a specific marker compound, typically ellagic acid for pomegranate-derived products. Preparative isolation and purification techniques for urolithins have been characterized in the research literature [2], providing validated methods for achieving consistent concentrations. A standardized extract is generally preferable to a non-standardized one because the amount delivered per serving is more predictable across batches.
References
- Roberts KM et al. Dose-Dependent Increases in Ellagitannin Metabolites as Biomarkers of Intake in Humans Consuming Standardized Black Raspberry Food Products Designed for Clinical Trials. Molecular nutrition & food research (2020). PMID 32112501
- Zhao W et al. Preparative isolation and purification of urolithins from the intestinal metabolites of pomegranate ellagitannins by high-speed counter-current chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2015). PMID 25864012
- Korczak M et al. Synthesis, characterization, and anti-inflammatory potential of serotonin- and dopamine-conjugates of urolithin A. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2025). PMID 40554288
- Wang YH et al. Development of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for characterizing pomegranate extract pharmacokinetics in humans. Journal of pharmaceutical and biomedical analysis (2023). PMID 37267874
- Heyns IM et al. UPLC-MS/MS Method for Simultaneous Quantification of Cyclosporine A and Urolithin A in Plasma and Interspecies Analysis Across Mammals Including Humans. ACS omega (2025). PMID 39959077
- Lin IC et al. Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells. Evidence-based complementary and alternative medicine : eCAM (2023). PMID 37706115
- DomĂnguez-LĂłpez I et al. Urinary polyphenol signature of the Mediterranean diet is associated with lower cardiovascular disease risk: the PREDIMED trial. BMC medicine (2025). PMID 41408634
- Singh A et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. European journal of clinical nutrition (2022). PMID 34117375
- Begoña Cerdá et al. Metabolism of Antioxidant and Chemopreventive Ellagitannins from Strawberries, Raspberries, Walnuts, and Oak-Aged Wine in Humans: Identification of Biomarkers and Individual Variability. Journal of Agricultural and Food Chemistry (2004). PMID 15656654
- Begoña Cerdá et al. Repeated Oral Administration of High Doses of the Pomegranate Ellagitannin Punicalagin to Rats for 37 Days Is Not Toxic. Journal of Agricultural and Food Chemistry (2003). PMID 12744688
- Aichinger G Natural Dibenzo-α-Pyrones: Friends or Foes?. International journal of molecular sciences (2021). PMID 34884865
- U.S. Food and Drug Administration Agency Response Letter GRAS Notice No. GRN 000791. U.S. Food and Drug Administration (2018). source
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.